Barroso, E.B.C. et al. 2026. Dual anti-human epidermal growth factor receptortype 2 blockade with taxane as first-line treatment for HER2-positive breast cancer with visceral metastases: a technology incorporation assessment within the Brazilian Unified Health System. Mastology. 35, suppl.1 (Feb. 2026). DOI:https://doi.org/10.29289/259453942025V35S1055.